OnCore Login

Return to Trial Database

HCRN-GYN97-1

A Phase II Study of Intraperitoneal 32p and Vaginal Brachytherapy in the Treatment of Papillary Serous and Clear Cell Adenocarcinoma of the Endometrium

Status

Study Completed

Cancer Type(s)

Endometrial

Study Contact

Publications

Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: A Phase II Study
  • AJ Fakiris, HR Cardenes, DH Moore, SR Reddy, KY Look, CT Yiannoutsos, ME Randall
Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: A Phase II Study
  • AJ Fakiris, HR Cardenes, DH Moore, SR Reddy, KY Look, CT Yiannoutsos, ME Randall

Trial Locations

All sites in which the trial HCRN-GYN97-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278